The UK Infected Blood Inquiry: A Personal Reflection.

Area of Science:

• Medical history
• Public health policy
• Infectious diseases

Background:

• The UK Infected Blood Inquiry (IBI) investigated deaths from transfusion-transmitted infections like hepatitis B, C, and HIV, and vCJD.
• The inquiry, spanning 2018-2024, reported significant findings on May 20, 2024, highlighting systemic failures.
• A personal reflection focuses on individuals with haemophilia infected through blood products, examining the long history of understanding these infections.

Purpose of the Study:

• To reflect on the historical context of treating haemophilia with blood products.
• To analyze the findings of the UK Infected Blood Inquiry regarding transfusion-transmitted infections.
• To advocate for improved patient compensation and the protection of evidence-based medicine.

Main Methods:

• Review of the UK Infected Blood Inquiry's findings and report.
• Historical analysis of medical practices in treating haemophilia over 40 years.
• Personal reflection on the experiences of physicians and patients.

Main Results:

• The IBI concluded at least 3000 deaths resulted from "recklessness and obstinacy of officialdom."
• Estimated compensation for victims ranges from £12 billion to £14 billion.
• Physicians' efforts to advance patient care with blood products were criticized despite unforeseen side effects.

Conclusions:

• The inquiry's findings underscore the tragic consequences of infected blood transfusions.
• There is a strong recommendation for establishing 'no-fault compensation' schemes.
• Protecting evidence-based medicine is crucial, especially with emerging irreversible therapies.